Riyadh contributes half of Saudi non-oil GDP as KPMG identifies 4 priorities for next growth phase

Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson?

These two high-quality dividend payers have had very different fortunes recently.

• Abbott Laboratories has faced revenue and earnings growth challenges
• Johnson & Johnson outperformed market indices this year
• Abbott's recent difficulties include lawsuits over baby formula

2h ago ·fool.com

Oracle vs. Amazon: Which Is the Better AI Cloud Stock to Own for the Next 5 Years?

Oracle has sold off since last fall, but does that make its stock a better bargain than Amazon's?

2h ago ·fool.com

If a Bear Market Is Coming, Here's What All of the Smartest Investors Are Doing Right Now

There is a bear market waiting to pounce at some point in the future, so you'll want to act now to make sure you avoid panicking.

2h ago ·fool.com

Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson?

Key PointsAbbott Laboratories has faced challenges, but it should successfully overcome them.

2h ago ·nasdaq.com